Aclaris Therapeutics (ACRS) Treasury Shares (2014 - 2026)

Aclaris Therapeutics' Treasury Shares history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 54.05% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 54.05% YoY), while the FY2025 annual figure was $320840.0, down 84.69% from the prior year.
• Treasury Shares was $1.5 million for Q1 2026 at Aclaris Therapeutics, up from $320840.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.2 million in Q1 2025 to a low of $69480.0 in Q2 2025.
• Historically, Treasury Shares has averaged $1.9 million across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 21092.3% in 2022, then plunged 97.77% in 2025.
• A 5-year view of Treasury Shares shows it stood at $1.5 million in 2022, then grew by 0.08% to $1.5 million in 2023, then soared by 37.73% to $2.1 million in 2024, then slumped by 84.69% to $320840.0 in 2025, then jumped by 354.68% to $1.5 million in 2026.
• The last three Treasury Shares figures came in at $1.5 million (Q1 2026), $320840.0 (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.